reGenics is a marine biotech company that leverage the science of unfertilized salmon roe to combat a global health problem: wound healing, diabetic ulcers and psoriasis. The company was one of the very few that was given the seal of excellence from EU, which makes it highly valued by associated and potential partners. One of them being a global well-known wound healing company , which also makes the case for possible exit opportunities in this intriguing investment case.